amisulpride 200mg tablets
dowelhurst ltd - amisulpride - oral tablet - 200mg
amisulpride 200mg tablets
kent pharma (uk) ltd - amisulpride - oral tablet - 200mg
amisulpride 200mg tablets
accord-uk ltd - amisulpride - oral tablet - 200mg
amisulpride 200mg tablets
mawdsley-brooks & company ltd - amisulpride - oral tablet - 200mg
amisulpride 200mg tablets
teva uk ltd - amisulpride - oral tablet - 200mg
amisulpride 200mg tablets
phoenix healthcare distribution ltd - amisulpride - oral tablet - 200mg
amisulpride 200mg tablets
waymade healthcare plc - amisulpride - oral tablet - 200mg
solian 200
sanofi-aventis new zealand limited - amisulpride 200mg; ; ; amisulpride 200mg - tablet - 200 mg - active: amisulpride 200mg excipient: hydrated silica lactose monohydrate magnesium stearate methylcellulose potato starch active: amisulpride 200mg excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
amisulpride sandoz pharma amisulpride 200 mg uncoated tablet blister pack
southern cross pharma pty ltd - amisulpride, quantity: 200 mg - tablet, uncoated - excipient ingredients: hypromellose; lactose monohydrate; microcrystalline cellulose; magnesium stearate; sodium starch glycollate type a - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
amisulpride sandoz pharma amisulpride 100 mg uncoated tablet blister pack
southern cross pharma pty ltd - amisulpride, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; sodium starch glycollate type a; hypromellose - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.